Literature DB >> 10510373

Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.

H T Kreuwel1, D J Morgan, T Krahl, A Ko, N Sarvetnick, L A Sherman.   

Abstract

CD8+ cytotoxic T cells play a critical role in initiating insulin-dependent diabetes mellitus. The relative contribution of each of the major cytotoxic pathways, perforin/granzyme and Fas/Fas ligand (FasL), in the induction of autoimmune diabetes remains controversial. To evaluate the role of each lytic pathway in beta cell lysis and induction of diabetes, we have used a transgenic mouse model in which beta cells expressing the influenza virus hemagglutinin (HA) are destroyed by HA-specific CD8+ T cells from clone-4 TCR-transgenic mice. Upon adoptive transfer of CD8+ T cells from perforin-deficient clone-4 TCR mice, there was a 30-fold increase in the number of T cells required to induce diabetes. In contrast, elimination of the Fas/FasL pathway of cytotoxicity had little consequence. When both pathways of cytolysis were eliminated, mice did not become diabetic. Using a model of spontaneous diabetes, which occurs in double transgenic neonates that express both clone-4 TCR and Ins-HA transgenes, mice deficient in either the perforin or FasL/Fas lytic pathway become diabetic soon after birth. This indicates that, in the neonate, large numbers of autoreactive CD8+ T cells can lead to destruction of islet beta cells by either pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510373

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity.

Authors:  Kazuyuki Akane; Seiji Kojima; Tak W Mak; Hiroshi Shiku; Haruhiko Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

Review 3.  The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

Authors:  H T Kreuwel; L A Sherman
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

4.  Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.

Authors:  Dongmei Han; Carlos A Leyva; Della Matheson; Davide Mineo; Shari Messinger; Bonnie B Blomberg; Ana Hernandez; Luigi F Meneghini; Gloria Allende; Jay S Skyler; Rodolfo Alejandro; Alberto Pugliese; Norma S Kenyon
Journal:  Clin Immunol       Date:  2011-02-24       Impact factor: 3.969

5.  Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function.

Authors:  A C Bateman; S M Turner; K S A Thomas; P R McCrudden; D R Fine; P A Johnson; C D Johnson; J P Iredale
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 6.  Combination Immunotherapy for Type 1 Diabetes.

Authors:  Robert N Bone; Carmella Evans-Molina
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

7.  Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.

Authors:  Anil Shanker; Samuel T Pellom; Duafalia F Dudimah; Menaka C Thounaojam; Rachel L de Kluyver; Alan D Brooks; Hideo Yagita; Daniel W McVicar; William J Murphy; Dan L Longo; Thomas J Sayers
Journal:  Cancer Res       Date:  2015-10-22       Impact factor: 12.701

8.  Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.

Authors:  Annahita K Sarcon; Marie J Desierto; Wenjun Zhou; Valeria Visconte; Federica Gibellini; Jichun Chen; Neal S Young
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

Review 9.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

10.  Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.

Authors:  Anil Shanker; Alan D Brooks; Kristen M Jacobsen; John W Wine; Robert H Wiltrout; Hideo Yagita; Thomas J Sayers
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.